The median age at death (31.4 years) observed in the CF population in Finland during the follow-up period, prior to the availability of CFTR modulators, was much lower than that in the general population of Finland, which was 85 years in women and 77 years in men in 2019 [22]. The gene discussed is CFTR; the disease is cystic fibrosis.